320 related articles for article (PubMed ID: 23292238)
21. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
22. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
23. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
[TBL] [Abstract][Full Text] [Related]
24. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
25. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
[TBL] [Abstract][Full Text] [Related]
26. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
[TBL] [Abstract][Full Text] [Related]
27. Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
Tichelli A; Rovó A
Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128
[TBL] [Abstract][Full Text] [Related]
28. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
30. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Patel SS; Rybicki LA; Corrigan D; Bolwell B; Dean R; Liu H; Gerds AT; Hanna R; Hill B; Jagadeesh D; Kalaycio M; Pohlman B; Sobecks R; Majhail NS; Hamilton BK
Biol Blood Marrow Transplant; 2018 May; 24(5):1029-1034. PubMed ID: 29369800
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
[TBL] [Abstract][Full Text] [Related]
33. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.
Kurosawa S; Yakushijin K; Yamaguchi T; Atsuta Y; Nagamura-Inoue T; Akiyama H; Taniguchi S; Miyamura K; Takahashi S; Eto T; Ogawa H; Kurokawa M; Tanaka J; Kawa K; Kato K; Suzuki R; Morishima Y; Sakamaki H; Fukuda T
Bone Marrow Transplant; 2013 Sep; 48(9):1198-204. PubMed ID: 23562971
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
35. Second malignancies after allogeneic hematopoietic cell transplantation.
Lowe T; Bhatia S; Somlo G
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1121-34. PubMed ID: 17889348
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation.
Ragbourne SC; Crook MA
Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):340-346. PubMed ID: 28622958
[TBL] [Abstract][Full Text] [Related]
37. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Lint MT; Wingard JR; Tichelli A
Rev Bras Hematol Hemoter; 2012; 34(2):109-33. PubMed ID: 23049402
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Rovó A; Tichelli A;
Semin Hematol; 2012 Jan; 49(1):25-34. PubMed ID: 22221782
[TBL] [Abstract][Full Text] [Related]
39. [Long-term follow-up study of allogeneic hematopoietic stem cell transplantation].
Doki N
Rinsho Ketsueki; 2015 Mar; 56(3):304-11. PubMed ID: 25876784
[TBL] [Abstract][Full Text] [Related]
40. Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.
Fu S; Rybicki L; Abounader D; Andresen S; Bolwell BJ; Dean R; Gerds A; Hamilton BK; Hanna R; Hill BT; Jagadeesh D; Kalaycio ME; Liu HD; Pohlman B; Sobecks RM; Majhail NS
Bone Marrow Transplant; 2015 Oct; 50(10):1326-30. PubMed ID: 26191953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
